141 related articles for article (PubMed ID: 26347939)
1. 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
Mascarin A; Valverde IE; Vomstein S; Mindt TL
Bioconjug Chem; 2015 Oct; 26(10):2143-52. PubMed ID: 26347939
[TBL] [Abstract][Full Text] [Related]
2. Probing the Backbone Function of Tumor Targeting Peptides by an Amide-to-Triazole Substitution Strategy.
Valverde IE; Vomstein S; Fischer CA; Mascarin A; Mindt TL
J Med Chem; 2015 Sep; 58(18):7475-84. PubMed ID: 26309061
[TBL] [Abstract][Full Text] [Related]
3. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
4. 1,2,3-Triazoles as amide-bond surrogates in peptidomimetics.
Valverde IE; Mindt TL
Chimia (Aarau); 2013; 67(4):262-6. PubMed ID: 23967702
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
[TBL] [Abstract][Full Text] [Related]
6. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
[TBL] [Abstract][Full Text] [Related]
7. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
[TBL] [Abstract][Full Text] [Related]
8. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA
Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeled antagonistic bombesin peptidomimetics for tumor targeting.
Valverde IE; Huxol E; Mindt TL
J Labelled Comp Radiopharm; 2014 Apr; 57(4):275-8. PubMed ID: 24327435
[TBL] [Abstract][Full Text] [Related]
10. Triazolo-Peptidomimetics: Novel Radiolabeled Minigastrin Analogs for Improved Tumor Targeting.
Grob NM; Häussinger D; Deupi X; Schibli R; Behe M; Mindt TL
J Med Chem; 2020 May; 63(9):4484-4495. PubMed ID: 32302139
[TBL] [Abstract][Full Text] [Related]
11. Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
Magafa V; Matsoukas MT; Karageorgos V; Dermitzaki E; Exarchakou R; Stylos EΚ; Pardalos M; Margioris AN; Varvounis G; Tzakos AG; Spyroulias GA; Liapakis G
Amino Acids; 2019 Jul; 51(7):1009-1022. PubMed ID: 31079216
[TBL] [Abstract][Full Text] [Related]
12. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
[TBL] [Abstract][Full Text] [Related]
13. 1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity.
Rečnik LM; Kandioller W; Mindt TL
Molecules; 2020 Aug; 25(16):. PubMed ID: 32781656
[TBL] [Abstract][Full Text] [Related]
14. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
[TBL] [Abstract][Full Text] [Related]
15. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
Zhang K; An R; Gao Z; Zhang Y; Aruva MR
Nucl Med Biol; 2006 May; 33(4):505-12. PubMed ID: 16720242
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting.
Falciani C; Fabbrini M; Pini A; Lozzi L; Lelli B; Pileri S; Brunetti J; Bindi S; Scali S; Bracci L
Mol Cancer Ther; 2007 Sep; 6(9):2441-8. PubMed ID: 17766836
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationship Studies of Amino Acid Substitutions in Radiolabeled Neurotensin Conjugates.
Mascarin A; Valverde IE; Mindt TL
ChemMedChem; 2016 Jan; 11(1):102-7. PubMed ID: 26593062
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors.
García-Garayoa E; Allemann-Tannahill L; Bläuenstein P; Willmann M; Carrel-Rémy N; Tourwé D; Iterbeke K; Conrath P; Schubiger PA
Nucl Med Biol; 2001 Jan; 28(1):75-84. PubMed ID: 11182567
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
García-Garayoa E; Bläuenstein P; Bruehlmeier M; Blanc A; Iterbeke K; Conrath P; Tourwé D; Schubiger PA
J Nucl Med; 2002 Mar; 43(3):374-83. PubMed ID: 11884498
[TBL] [Abstract][Full Text] [Related]
20. A novel tetrabranched neurotensin(8-13) cyclam derivative: synthesis, 64Cu-labeling and biological evaluation.
Röhrich A; Bergmann R; Kretzschmann A; Noll S; Steinbach J; Pietzsch J; Stephan H
J Inorg Biochem; 2011 Jun; 105(6):821-32. PubMed ID: 21497581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]